• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2009年至2015年期间,美国学龄儿童和青少年中注意力缺陷多动障碍的治疗患病率有所上升。

Treated Prevalence of Attention-Deficit/Hyperactivity Disorder Increased from 2009 to 2015 Among School-Aged Children and Adolescents in the United States.

作者信息

Nyarko Kwame A, Grosse Scott D, Danielson Melissa L, Holbrook Joseph R, Visser Susanna N, Shapira Stuart K

机构信息

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention , Atlanta, Georgia .

出版信息

J Child Adolesc Psychopharmacol. 2017 Oct;27(8):731-734. doi: 10.1089/cap.2016.0196. Epub 2017 Mar 22.

DOI:10.1089/cap.2016.0196
PMID:28328236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5610057/
Abstract

OBJECTIVES

The purpose of this brief is to describe changes in the treated prevalence of medically managed attention-deficit/hyperactivity disorder (ADHD) among insured school-aged children and adolescents in the United States from 2009 to 2015. We examine the differences between those with employer-sponsored insurance (ESI) and with Medicaid insurance.

METHODS

We utilized two large longitudinal administrative datasets containing medical and drug claims data on individuals with ESI and Medicaid insurance from Truven Health MarketScan Administrative Claims Databases. Treated prevalence was measured as the percentage of school-aged children and adolescents enrolled in a calendar year who met the criteria for medically managed ADHD in the same calendar year. Subjects were eligible for inclusion if they were aged 6-17 years and were continuously enrolled during a calendar year.

RESULTS

The annual prevalence of treated ADHD among school-aged children and adolescents with ESI increased from 4.5% in 2009 to 6.7% in 2015. Among those with Medicaid it increased from 11.3% in 2009 to 13.3% in 2012, and fell after 2012, remaining steady from 2013 through 2015.

CONCLUSION

Treated prevalence of ADHD increased continuously over time among school-aged children and adolescents with ESI, but declined slightly after 2012 among those in the Medicaid sample.

摘要

目的

本简报旨在描述2009年至2015年美国参保学龄儿童和青少年中药物治疗注意力缺陷多动障碍(ADHD)的治疗患病率变化情况。我们研究了有雇主赞助保险(ESI)者和有医疗补助保险者之间的差异。

方法

我们利用了两个大型纵向管理数据集,这些数据集包含来自Truven Health MarketScan管理索赔数据库的有关ESI和医疗补助保险个人的医疗和药物索赔数据。治疗患病率的衡量标准是在同一年符合药物治疗ADHD标准的学龄儿童和青少年在该日历年的参保百分比。如果受试者年龄在6至17岁之间且在一个日历年中持续参保,则符合纳入条件。

结果

有ESI的学龄儿童和青少年中ADHD的年度治疗患病率从2009年的4.5%增至2015年的6.7%。有医疗补助保险者中,该患病率从2009年的11.3%增至2012年的13.3%,2012年后下降,2013年至2015年保持稳定。

结论

有ESI的学龄儿童和青少年中ADHD的治疗患病率随时间持续上升,但医疗补助保险样本中的患病率在2012年后略有下降。

相似文献

1
Treated Prevalence of Attention-Deficit/Hyperactivity Disorder Increased from 2009 to 2015 Among School-Aged Children and Adolescents in the United States.2009年至2015年期间,美国学龄儿童和青少年中注意力缺陷多动障碍的治疗患病率有所上升。
J Child Adolesc Psychopharmacol. 2017 Oct;27(8):731-734. doi: 10.1089/cap.2016.0196. Epub 2017 Mar 22.
2
Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2-5 Years - United States, 2008-2014.生命体征:2008-2014 年美国 2-5 岁有保险儿童注意缺陷多动障碍治疗的国家和州别模式。
MMWR Morb Mortal Wkly Rep. 2016 May 6;65(17):443-50. doi: 10.15585/mmwr.mm6517e1.
3
Health care utilization by children with chronic illnesses: a comparison of medicaid and employer-insured managed care.慢性病患儿的医疗保健利用情况:医疗补助与雇主投保管理式医疗的比较
Pediatrics. 1998 Oct;102(4):E44. doi: 10.1542/peds.102.4.e44.
4
Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.医疗补助数据库中患有注意力缺陷/多动障碍的青少年的药物治疗使用情况。
Ann Pharmacother. 2008 Jan;42(1):24-31. doi: 10.1345/aph.1K143. Epub 2007 Nov 27.
5
Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011.2007 - 2011年韩国儿童和青少年注意力缺陷多动障碍药物的处方模式
Epidemiol Health. 2016 Oct 26;38:e2016045. doi: 10.4178/epih.e2016045. eCollection 2016.
6
Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.患有注意缺陷多动障碍和/或行为障碍的幼儿比兴奋剂更常被开处阿尔法激动剂。
J Child Adolesc Psychopharmacol. 2020 Mar;30(2):81-86. doi: 10.1089/cap.2019.0105. Epub 2019 Oct 17.
7
Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications.医疗补助计划参保儿童及青少年使用非典型抗精神病药物的情况:用药时长、安全性及监测意义
J Child Adolesc Psychopharmacol. 2014 Apr;24(3):112-9. doi: 10.1089/cap.2013.0094. Epub 2014 Apr 1.
8
Disruption of Pharmacotherapy During the Transition from Adolescence to Early Adulthood in Patients with Attention-Deficit/Hyperactivity Disorder: A Claims Database Analysis Across the USA.注意缺陷多动障碍患者从青春期向成年早期过渡期间药物治疗中断:一项跨越美国的索赔数据库分析。
CNS Drugs. 2021 May;35(5):575-589. doi: 10.1007/s40263-021-00808-x. Epub 2021 Apr 15.
9
Adult ADHD: prevalence of diagnosis in a US population with employer health insurance.成人注意缺陷多动障碍:有雇主健康保险的美国人群中的诊断患病率。
Curr Med Res Opin. 2011;27 Suppl 2:5-11. doi: 10.1185/03007995.2011.603302.
10
Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents With Congenital Adrenal Hyperplasia.美国先天性肾上腺皮质增生症儿童及青少年中的注意力缺陷/多动障碍
J Endocr Soc. 2020 Oct 14;4(12):bvaa152. doi: 10.1210/jendso/bvaa152. eCollection 2020 Dec 1.

引用本文的文献

1
Trends in the prevalence of pediatric lower urinary tract symptoms in a national claims database of privately insured patients, 2007-2016.2007 - 2016年私人保险患者全国索赔数据库中儿童下尿路症状患病率的趋势
Front Urol. 2025 Apr 16;5:1422897. doi: 10.3389/fruro.2025.1422897. eCollection 2025.
2
Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use.在儿童和青少年多动症诊断率和药物使用率不断上升的背景下,对多动症作为一种社会建构的观点。
Front Psychiatry. 2024 Jan 5;14:1289157. doi: 10.3389/fpsyt.2023.1289157. eCollection 2023.
3
Prevalence of diagnosed depression, anxiety, and ADHD among youth with type 1 or type 2 diabetes mellitus.1 型或 2 型糖尿病青少年中确诊的抑郁、焦虑和 ADHD 的患病率。
Prim Care Diabetes. 2023 Dec;17(6):658-660. doi: 10.1016/j.pcd.2023.09.004. Epub 2023 Sep 22.
4
Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review.儿童和青少年注意缺陷多动障碍的过度诊断:系统范围综述。
JAMA Netw Open. 2021 Apr 1;4(4):e215335. doi: 10.1001/jamanetworkopen.2021.5335.
5
Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents With Congenital Adrenal Hyperplasia.美国先天性肾上腺皮质增生症儿童及青少年中的注意力缺陷/多动障碍
J Endocr Soc. 2020 Oct 14;4(12):bvaa152. doi: 10.1210/jendso/bvaa152. eCollection 2020 Dec 1.
6
Community-Based Prevalence of Externalizing and Internalizing Disorders among School-Aged Children and Adolescents in Four Geographically Dispersed School Districts in the United States.基于社区的美国四个地理分散学区学龄儿童和青少年的外化和内化障碍患病率。
Child Psychiatry Hum Dev. 2021 Jun;52(3):500-514. doi: 10.1007/s10578-020-01027-z.
7
Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009-2017.美国儿童发育障碍的患病率和趋势:2009-2017 年。
Pediatrics. 2019 Oct;144(4). doi: 10.1542/peds.2019-0811.
8
Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data.儿童和青少年精神药物的处方流行率:国际数据分析。
Eur J Clin Pharmacol. 2019 Oct;75(10):1333-1346. doi: 10.1007/s00228-019-02711-3. Epub 2019 Jul 4.
9
Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016.2006 年至 2016 年美国属地处方兴奋剂使用趋势。
PLoS One. 2018 Nov 28;13(11):e0206100. doi: 10.1371/journal.pone.0206100. eCollection 2018.
10
Addressing Discrepancies Between ADHD Prevalence and Case Identification Estimates Among U.S. Children Utilizing NSCH 2007-2012.利用 2007-2012 年 NSCH 数据解决美国儿童注意缺陷多动障碍患病率与病例识别估计值之间的差异。
J Atten Disord. 2019 Dec;23(14):1691-1702. doi: 10.1177/1087054718799930. Epub 2018 Sep 28.

本文引用的文献

1
Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2-5 Years - United States, 2008-2014.生命体征:2008-2014 年美国 2-5 岁有保险儿童注意缺陷多动障碍治疗的国家和州别模式。
MMWR Morb Mortal Wkly Rep. 2016 May 6;65(17):443-50. doi: 10.15585/mmwr.mm6517e1.
2
Racial and ethnic disparities in parent-reported diagnosis of ADHD: National Survey of Children's Health (2003, 2007, and 2011).家长报告的注意力缺陷多动障碍诊断中的种族和族裔差异:全国儿童健康调查(2003年、2007年和2011年)
J Clin Psychiatry. 2016 Jan;77(1):52-9. doi: 10.4088/JCP.14m09364.
3
Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.医疗服务提供者诊断并用药治疗的注意力缺陷/多动障碍的家长报告趋势:美国,2003 - 2011年
J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):34-46.e2. doi: 10.1016/j.jaac.2013.09.001. Epub 2013 Nov 21.
4
The prevalence of ADHD: its diagnosis and treatment in four school districts across two states.注意缺陷多动障碍(ADHD)的流行情况:在两个州的四个学区的诊断和治疗。
J Atten Disord. 2014 Oct;18(7):563-75. doi: 10.1177/1087054712453169. Epub 2012 Sep 5.
5
Attention deficit hyperactivity disorder among children aged 5-17 years in the United States, 1998-2009.1998 - 2009年美国5至17岁儿童的注意力缺陷多动障碍
NCHS Data Brief. 2011 Aug(70):1-8.
6
ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.ADHD:儿童和青少年注意缺陷多动障碍的诊断、评估和治疗的临床实践指南。
Pediatrics. 2011 Nov;128(5):1007-22. doi: 10.1542/peds.2011-2654. Epub 2011 Oct 16.
7
Trends in the prevalence of developmental disabilities in US children, 1997-2008.美国儿童发育障碍患病率的趋势,1997-2008 年。
Pediatrics. 2011 Jun;127(6):1034-42. doi: 10.1542/peds.2010-2989. Epub 2011 May 23.
8
Developmental comorbidity in attention-deficit/hyperactivity disorder.注意缺陷多动障碍中的发育共病
Atten Defic Hyperact Disord. 2010 Dec;2(4):267-89. doi: 10.1007/s12402-010-0040-0. Epub 2010 Nov 10.
9
Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.注意缺陷/多动障碍儿童和青少年评估与治疗的实践参数
J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894-921. doi: 10.1097/chi.0b013e318054e724.
10
Co-existing psychiatric problems in ADHD in the ADORE cohort.ADORE队列中多动症患者并存的精神问题。
Eur Child Adolesc Psychiatry. 2006 Dec;15 Suppl 1:I25-9. doi: 10.1007/s00787-006-1004-y.